| scholarly article | Q13442814 |
| P2093 | author name string | Jie Zhang | |
| Silvia G Priori | |||
| Nian Liu | |||
| Guoxin Kang | |||
| Glenn I Fishman | |||
| Fang-Yu Liu | |||
| Steven F Giovannone | |||
| P2860 | cites work | Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans | Q24608179 |
| Wide long lasting perinuclear Ca2+ release events generated by an interaction between ryanodine and IP3 receptors in canine Purkinje cells | Q24653592 | ||
| Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia | Q28201561 | ||
| A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel | Q28204838 | ||
| Disruption of calcium homeostasis and arrhythmogenesis induced by mutations in the cardiac ryanodine receptor and calsequestrin | Q28257514 | ||
| RyR2 mutations linked to ventricular tachycardia and sudden death reduce the threshold for store-overload-induced Ca2+ release (SOICR) | Q28278038 | ||
| Catecholaminergic polymorphic ventricular tachycardia | Q28287523 | ||
| Arrhythmogenic mechanisms in a mouse model of catecholaminergic polymorphic ventricular tachycardia | Q28595062 | ||
| Ca(2+) transients and Ca(2+) waves in purkinje cells : role in action potential initiation | Q30843462 | ||
| Mapping and ablation of ventricular fibrillation associated with long-QT and Brugada syndromes | Q33149255 | ||
| Bidirectional ventricular tachycardia and fibrillation elicited in a knock-in mouse model carrier of a mutation in the cardiac ryanodine receptor. | Q33152686 | ||
| Increased Ca2+ sensitivity of the ryanodine receptor mutant RyR2R4496C underlies catecholaminergic polymorphic ventricular tachycardia | Q33551271 | ||
| Flecainide inhibits arrhythmogenic Ca2+ waves by open state block of ryanodine receptor Ca2+ release channels and reduction of Ca2+ spark mass. | Q33618629 | ||
| Diastolic intracellular calcium-membrane voltage coupling gain and postshock arrhythmias: role of purkinje fibers and triggered activity. | Q33639479 | ||
| Reduced intercellular coupling leads to paradoxical propagation across the Purkinje-ventricular junction and aberrant myocardial activation. | Q33932684 | ||
| Immunocytochemical analysis of connexin expression in the healthy and diseased cardiovascular system | Q34141781 | ||
| Contactin-2 expression in the cardiac Purkinje fiber network | Q34747800 | ||
| Induction and patterning of the cardiac conduction system. | Q34969544 | ||
| Calcium overload and cardiac function | Q35865477 | ||
| Toward an understanding of the genetics of murine cardiac pacemaking and conduction system development. | Q35887928 | ||
| Dantrolene, a therapeutic agent for malignant hyperthermia, markedly improves the function of failing cardiomyocytes by stabilizing interdomain interactions within the ryanodine receptor. | Q37393446 | ||
| Catecholaminergic polymorphic ventricular tachycardia: A paradigm to understand mechanisms of arrhythmias associated to impaired Ca(2+) regulation | Q37625277 | ||
| Enhanced basal activity of a cardiac Ca2+ release channel (ryanodine receptor) mutant associated with ventricular tachycardia and sudden death | Q40711729 | ||
| Na+-dependent SR Ca2+ overload induces arrhythmogenic events in mouse cardiomyocytes with a human CPVT mutation. | Q43191839 | ||
| Role of left ventricular scar and Purkinje-like potentials during mapping and ablation of ventricular fibrillation in dilated cardiomyopathy | Q46094843 | ||
| Verapamil-sensitive left anterior fascicular ventricular tachycardia associated with a healed myocardial infarction: changes in the delayed Purkinje potential during sinus rhythm | Q46502397 | ||
| Unexpected structural and functional consequences of the R33Q homozygous mutation in cardiac calsequestrin: a complex arrhythmogenic cascade in a knock in mouse model | Q46516049 | ||
| Architectural and functional asymmetry of the His-Purkinje system of the murine heart. | Q47352047 | ||
| Reduced calcium currents in subendocardial Purkinje myocytes that survive in the 24- and 48-hour infarcted heart | Q48108255 | ||
| Reduced inward rectifying and increased E-4031-sensitive K+ current density in arrhythmogenic subendocardial purkinje myocytes from the infarcted heart | Q48485470 | ||
| Reducing ryanodine receptor open probability as a means to abolish spontaneous Ca2+ release and increase Ca2+ transient amplitude in adult ventricular myocytes. | Q48708332 | ||
| Interrelationships Between Automaticity and Conduction in Purkinje Fibers | Q51204643 | ||
| T-tubule profiles in Purkinje fibres of mammalian myocardium. | Q51983091 | ||
| Electrotonic suppression of early afterdepolarizations in isolated rabbit Purkinje myocytes. | Q54044181 | ||
| Electrophysiology and ultrastructure of canine subendocardial Purkinje cells isolated from control and 24-hour infarcted hearts | Q69747792 | ||
| Transient Outward Currents in Subendocardial Purkinje Myocytes Surviving in the Infarcted Heart | Q71955998 | ||
| Effects of mibefradil, a T-type calcium current antagonist, on electrophysiology of Purkinje fibers that survived in the infarcted canine heart | Q73074377 | ||
| Ionic remodeling of cardiac Purkinje cells by congestive heart failure | Q74843560 | ||
| Role of Purkinje conducting system in triggering of idiopathic ventricular fibrillation | Q77731640 | ||
| Comparison of ion-channel subunit expression in canine cardiac Purkinje fibers and ventricular muscle | Q78460665 | ||
| Role of Purkinje fibers in post-infarction ventricular tachycardia | Q79437836 | ||
| Arrhythmogenesis in catecholaminergic polymorphic ventricular tachycardia: insights from a RyR2 R4496C knock-in mouse model | Q79851890 | ||
| Novel mechanism of postinfarction ventricular tachycardia originating in surviving left posterior Purkinje fibers | Q80022321 | ||
| Role of subendocardial Purkinje network in triggering torsade de pointes arrhythmia in experimental long QT syndrome | Q81896618 | ||
| Variations in the functional electrical coupling between the subendocardial Purkinje and ventricular layers of the canine left ventricle | Q93594367 | ||
| P433 | issue | 4 | |
| P921 | main subject | Purkinje cell | Q1570272 |
| P304 | page(s) | 512-519 | |
| P577 | publication date | 2010-07-01 | |
| P1433 | published in | Circulation Research | Q2599020 |
| P1476 | title | Purkinje cells from RyR2 mutant mice are highly arrhythmogenic but responsive to targeted therapy | |
| P478 | volume | 107 |
| Q35126315 | A model of canine purkinje cell electrophysiology and Ca(2+) cycling: rate dependence, triggered activity, and comparison to ventricular myocytes |
| Q36696236 | Accelerated sinus rhythm prevents catecholaminergic polymorphic ventricular tachycardia in mice and in patients. |
| Q42065538 | Arrhythmogenic calmodulin mutations disrupt intracellular cardiomyocyte Ca2+ regulation by distinct mechanisms |
| Q35082640 | Atrial arrhythmogenesis in catecholaminergic polymorphic ventricular tachycardia--is there a mechanistic link between sarcoplasmic reticulum Ca(2+) leak and re-entry? |
| Q36604970 | Calcium alternans in cardiac myocytes: order from disorder |
| Q24300626 | Calsequestrin 2 and arrhythmias |
| Q28262015 | Calsequestrin mutations and catecholaminergic polymorphic ventricular tachycardia |
| Q35843505 | Cardiac cellular coupling and the spread of early instabilities in intracellular Ca2+. |
| Q38025386 | Cardiac conduction system anomalies and sudden cardiac death: insights from murine models. |
| Q36486478 | Cardiac ion channelopathies and the sudden infant death syndrome |
| Q48161835 | Catecholaminergic polymorphic ventricular tachycardia, an update. |
| Q27303698 | Channel Activity of Cardiac Ryanodine Receptors (RyR2) Determines Potency and Efficacy of Flecainide and R-Propafenone against Arrhythmogenic Calcium Waves in Ventricular Cardiomyocytes |
| Q36992757 | Constitutive Intracellular Na+ Excess in Purkinje Cells Promotes Arrhythmogenesis at Lower Levels of Stress Than Ventricular Myocytes From Mice With Catecholaminergic Polymorphic Ventricular Tachycardia |
| Q28076784 | Current topics in catecholaminergic polymorphic ventricular tachycardia |
| Q92226110 | Delayed afterdepolarization-induced triggered activity in cardiac purkinje cells mediated through cytosolic calcium diffusion waves |
| Q45262771 | Development and Function of the Cardiac Conduction System in Health and Disease |
| Q55517601 | ETV1 activates a rapid conduction transcriptional program in rodent and human cardiomyocytes. |
| Q33162208 | Effects of flecainide on exercise-induced ventricular arrhythmias and recurrences in genotype-negative patients with catecholaminergic polymorphic ventricular tachycardia. |
| Q38083549 | Electrical storm: recent pathophysiological insights and therapeutic consequences. |
| Q46139358 | Evoked centripetal Ca(2+) mobilization in cardiac Purkinje cells: insight from a model of three Ca(2+) release regions |
| Q43146405 | Extinguishing intracellular calcium leak: a promising antiarrhythmic approach |
| Q27333903 | Formation of spatially discordant alternans due to fluctuations and diffusion of calcium |
| Q36975788 | Gene mutations in cardiac arrhythmias: a review of recent evidence in ion channelopathies. |
| Q28307856 | Genetics of sudden cardiac death syndromes |
| Q37863374 | Genetics of sudden death: focus on inherited channelopathies. |
| Q34313368 | In situ confocal imaging in intact heart reveals stress-induced Ca(2+) release variability in a murine catecholaminergic polymorphic ventricular tachycardia model of type 2 ryanodine receptor(R4496C+/-) mutation |
| Q34160930 | Inhibition of cardiac Ca2+ release channels (RyR2) determines efficacy of class I antiarrhythmic drugs in catecholaminergic polymorphic ventricular tachycardia. |
| Q35565852 | Isolation and characterization of embryonic stem cell-derived cardiac Purkinje cells |
| Q89961129 | Molecular and tissue mechanisms of catecholaminergic polymorphic ventricular tachycardia |
| Q39215625 | Multiple targets for flecainide action: implications for cardiac arrhythmogenesis |
| Q100395099 | NOTCH1 is critical for fibroblast-mediated induction of cardiomyocyte specialization into ventricular conduction system-like cells in vitro |
| Q35961333 | Optogenetic determination of the myocardial requirements for extrasystoles by cell type-specific targeting of ChannelRhodopsin-2. |
| Q43138048 | PCP4 regulates Purkinje cell excitability and cardiac rhythmicity |
| Q38494265 | Pharmacotherapy for inherited arrhythmia syndromes: mechanistic basis, clinical trial evidence and practical application. |
| Q36328301 | Phenotypically silent Cre recombination within the postnatal ventricular conduction system |
| Q35974167 | Purkinje Cells as Sources of Arrhythmias in Long QT Syndrome Type 3. |
| Q90593329 | Purkinje physiology and pathophysiology |
| Q36610682 | Ryanodine receptor inhibition potentiates the activity of Na channel blockers against spontaneous calcium elevations and delayed afterdepolarizations in Langendorff-perfused rabbit ventricles. |
| Q59270311 | Ryanodine receptors |
| Q30433543 | Sudden cardiac death prediction and prevention: report from a National Heart, Lung, and Blood Institute and Heart Rhythm Society Workshop |
| Q37885158 | Targeting ryanodine receptors for anti-arrhythmic therapy |
| Q89479718 | The cardiac ryanodine receptor, but not sarcoplasmic reticulum Ca2+-ATPase, is a major determinant of Ca2+ alternans in intact mouse hearts |
| Q35751770 | The ionic bases of the action potential in isolated mouse cardiac Purkinje cell |
| Q35105380 | The sarcoplasmic reticulum luminal thiol oxidase ERO1 regulates cardiomyocyte excitation-coupled calcium release and response to hemodynamic load |
| Q37452234 | Transcription factor ETV1 is essential for rapid conduction in the heart |
| Q35737841 | Unique cardiac Purkinje fiber transient outward current β-subunit composition: a potential molecular link to idiopathic ventricular fibrillation. |
| Q38685887 | Ventricular arrhythmias and the His-Purkinje system. |
Search more.